Free Trial
OTCMKTS:CVSI

CV Sciences (CVSI) Stock Price, News & Analysis

CV Sciences logo
$0.04 +0.00 (+6.32%)
As of 03:22 PM Eastern

About CV Sciences Stock (OTCMKTS:CVSI)

Key Stats

Today's Range
$0.04
$0.04
50-Day Range
$0.03
$0.04
52-Week Range
$0.02
$0.05
Volume
15,120 shs
Average Volume
213,936 shs
Market Capitalization
$7.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CV Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
12th Percentile Overall Score

CVSI MarketRank™: 

CV Sciences scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CV Sciences.

  • Price to Book Value per Share Ratio

    CV Sciences has a P/B Ratio of 4.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.00% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CV Sciences does not currently pay a dividend.

  • Dividend Growth

    CV Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of CV Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    CV Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CV Sciences has recently increased by 6.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    CV Sciences has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for CV Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for CVSI on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added CV Sciences to their MarketBeat watchlist in the last 30 days.
Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

CVSI Stock News Headlines

CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
Q1 2025 CV Sciences Inc Earnings Call
See More Headlines

CVSI Stock Analysis - Frequently Asked Questions

CV Sciences' stock was trading at $0.0338 at the start of the year. Since then, CVSI stock has increased by 19.5% and is now trading at $0.0404.

CV Sciences, Inc. (OTCMKTS:CVSI) posted its earnings results on Thursday, August, 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.03). The company had revenue of $5.13 million for the quarter, compared to the consensus estimate of $5.12 million. CV Sciences had a negative net margin of 10.36% and a negative trailing twelve-month return on equity of 80.82%.

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Cronos Group (CRON), KUSHCO (KSHB), NVIDIA (NVDA) and Organigram Global (OGI).

Company Calendar

Last Earnings
8/12/2021
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CVSI
Previous Symbol
NASDAQ:CVSI
CIK
1510964
Employees
70
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.39 million
Net Margins
-10.36%
Pretax Margin
-10.41%
Return on Equity
-80.82%
Return on Assets
-19.38%

Debt

Debt-to-Equity Ratio
0.12
Current Ratio
1.04
Quick Ratio
0.30

Sales & Book Value

Annual Sales
$15.70 million
Price / Sales
0.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
4.04

Miscellaneous

Outstanding Shares
184,794,000
Free Float
177,772,000
Market Cap
$7.47 million
Optionable
Not Optionable
Beta
0.61

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:CVSI) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners